Readying the minimal residual disease concept in acute myeloid leukaemia for prime time - the American way

British Journal of Haematology

Volumn 162, Issue 4, 2013, Pages 429-430

  Hokland, Peter ^a   Cotter, Finbarr ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Acute leukaemia; Flow cytometry; Minimal residual disease; Molecular diagnostics; Regulation

Indexed keywords

ACCURACY; ACUTE GRANULOCYTIC LEUKEMIA; BLAST CELL; BONE MARROW CELL; EDITORIAL; FLOW CYTOMETRY; HUMAN; LEUKEMIA REMISSION; LYMPHOID CELL; MINIMAL RESIDUAL DISEASE; MYELOBLAST; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STANDARDIZATION; UNITED STATES;

ACUTE LEUKAEMIA; FLOW CYTOMETRY; MINIMAL RESIDUAL DISEASE; MOLECULAR DIAGNOSTICS; REGULATION;

ADULT; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BONE MARROW EXAMINATION; CHILD; CLINICAL TRIALS AS TOPIC; CONGRESSES AS TOPIC; DRUG APPROVAL; EUROPE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, MYELOID, ACUTE; MULTICENTER STUDIES AS TOPIC; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84880699888     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12419     Document Type: Editorial

References (8)

1. Beillard, E., Pallisgaard, N., van der Velden, V.H., Bi, W., Dee, R., van der Schoot, E., Delabesse, E., Macintyre, E., Gottardi, E., Saglio, G., Watzinger, F., Lion, T., van Dongen, J.J., Hokland, P. & Gabert, J. (2003) Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia, 17, 2474-2486.
2. Gabert, J., Beillard, E., van der Velden, V.H., Bi, W., Grimwade, D., Pallisgaard, N., Barbany, G., Cazzaniga, G., Cayuela, J.M., Cave, H., Pane, F., Aerts, J.L., De Micheli, D., Thirion, X., Pradel, V., Gonzalez, M., Viehmann, S., Malec, M., Saglio, G. & van Dongen, J.J. (2003) Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe against cancer program. Leukemia, 17, 2318-2357.
3. Goulden, N., Virgo, P. & Grimwade, D. (2006) Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now. British Journal of Haematology, 134, 273-282.
4. Hokland, P. & Ommen, H.B. (2011) Towards individualized follow-up in adult acute myeloid leukemia in remission. Blood, 117, 2577-2584.
5. Kohlmann, A., Grossmann, V., Nadarajah, N. & Haferlach, T. (2013) Next-generation sequencing - feasibility and practicality in haematology. British Journal of Haematology, 160, 736-753.
6. Ossenkoppele, G.J., van de Loosdrecht, A.A. & Schuurhuis, G.J. (2011) Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms. British Journal of Haematology, 153, 421-436.
7. van Rhenen, A., van Dongen, G.A., Kelder, A., Rombouts, E.J., Feller, N., Moshaver, B., Stigter-van Walsum, M., Zweegman, S., Ossenkoppele, G.J. & Jan Schuurhuis, G. (2007) The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. Blood, 110, 2659-2666.
8. Sutherland, D.R., Keeney, M. & Gratama, J.W. (2003) Enumeration of CD34 + hematopoietic stem and progenitor cells. Current Protocols in Cytometry, Chapter 6, Unit 6.4.